Skimmianine Showed Neuroprotection against Cerebral Ischemia/Reperfusion Injury
Open Access
- 12 July 2024
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (7) , 7373-7385
Abstract
The aim of this study was to investigate the antioxidant and anti-inflammatory effects of skimmianine on cerebral ischemia–reperfusion (IR) injury. Twenty-four female Wistar albino rats were randomly divided into three groups: Sham, Ischemia–Reperfusion (IR), and IR + Skimmianine (40 mg/kg Skimmianine). Cerebral ischemia was induced using a monofilament nylon suture to occlude the middle cerebral artery for 60 min. Following 23 h of reperfusion, the animals were sacrificed 14 days later. The effects of skimmianine on brain tissue post-IR injury were examined through biochemical and immunochemical analyses. In silico analysis using the Enrichr platform explored skimmianine’s potential biological processes involving IBA-1, IL-6, and NF-κB proteins. In the IR group, MDA levels increased, while SOD and CAT antioxidant enzyme activities decreased. In the IR + Skimmianine group, skimmianine treatment resulted in decreased MDA levels and increased SOD and CAT activities. Significant increases in IBA-1 expression were observed in the IR group, which skimmianine treatment significantly reduced, modulating microglial activation. High levels of IL-6 expression were noted in pyramidal neurons, vascular structures, and neuroglial cells in the IR group; skimmianine treatment reduced IL-6 expression, demonstrating anti-inflammatory effects. Increased NF-κB expression was observed in neurons and blood vessels in the gray and white matter in the IR group; skimmianine treatment reduced NF-κB expression. Gene Ontology results suggest skimmianine impacts immune and inflammatory responses via IBA-1 and IL-6, with potential effects on estrogen mechanisms mediated by NF-κB. Skimmianine may be a potential therapeutic strategy due to its antioxidant and anti-inflammatory effects on cerebral IR injury.Keywords
This publication has 64 references indexed in Scilit:
- Inflammatory biomarkers of ischemic strokeInternal and Emergency Medicine, 2023
- Methodological and reporting quality evaluation of Buyang Huanwu decoction for experimental cerebral ischemia–reperfusion injury: a systematic reviewNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A ReviewCellular and Molecular Neurobiology, 2022
- Interference with long noncoding RNA SNHG3 alleviates cerebral ischemia-reperfusion injury by inhibiting microglial activationJournal of Leukocyte Biology, 2021
- Noscapine alleviates cerebral damage in ischemia-reperfusion injury in ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Protection against acute cerebral ischemia/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilizationBiomedicine & Pharmacotherapy, 2020
- Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damageBiomedicine & Pharmacotherapy, 2019
- Allograft inflammatory factor-1 stimulates chemokine production and induces chemotaxis in human peripheral blood mononuclear cellsBiochemical and Biophysical Research Communications, 2014
- Anti-inflammatory effect of quinoline alkaloid skimmianine isolated from Ruta graveolens L.Inflammation Research, 2013
- Direct antioxidant and protective effect of estradiol on isolated mitochondriaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010